These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2123905)
1. Coronary artery patency in patients with myocardial infarction. Braunwald E J Am Coll Cardiol; 1990 Dec; 16(7):1550-2. PubMed ID: 2123905 [No Abstract] [Full Text] [Related]
2. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. White HD; Cross DB; Elliott JM; Norris RM; Yee TW Circulation; 1994 Jan; 89(1):61-7. PubMed ID: 8281696 [TBL] [Abstract][Full Text] [Related]
3. Angiographic monitoring of reperfusion therapy for acute myocardial infarction. TIMI grade 3 perfusion is the goal. Stadius ML Circulation; 1993 Jun; 87(6):2055-7. PubMed ID: 8504521 [No Abstract] [Full Text] [Related]
4. Association between admission mean platelet volume and coronary patency after thrombolytic therapy for acute myocardial infarction. Yaşar AS; Bilen E; Yüksel IO; Arslantaş U; Karakaş F; Kirbaş O; Bilge M Turk Kardiyol Dern Ars; 2010 Mar; 38(2):85-9. PubMed ID: 20473008 [TBL] [Abstract][Full Text] [Related]
5. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. GUSTO Angiographic Investigators N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430 [TBL] [Abstract][Full Text] [Related]
6. Impact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial Infarction. Gibson CM; Anshelevich M; Murphy S; Luu L; Hynes C; Kliris J; Kermgard S; Otten MH; Antman EM; Cannon CP; Braunwald E; Am J Cardiol; 2000 Dec; 86(12):1378-9, A5. PubMed ID: 11113418 [TBL] [Abstract][Full Text] [Related]
7. Effects of thrombolytic therapy on left ventricular function and the importance of long-term patency of the infarct-related artery. White HD Clin Sci (Lond); 1995 Jan; 88(1):21-4. PubMed ID: 7704995 [No Abstract] [Full Text] [Related]
8. Late potentials on signal-averaged electrocardiograms and patency of the infarct-related artery in survivors of acute myocardial infarction. Vatterott PJ; Hammill SC; Bailey KR; Wiltgen CM; Gersh BJ J Am Coll Cardiol; 1991 Feb; 17(2):330-7. PubMed ID: 1899434 [TBL] [Abstract][Full Text] [Related]
9. Aortic counterpulsation may improve late patency of the occluded coronary artery in patients with early failure of thrombolytic therapy. Kono T; Morita H; Nishina T; Fujita M; Onaka H; Hirota Y; Kawamura K; Fujiwara A J Am Coll Cardiol; 1996 Oct; 28(4):876-81. PubMed ID: 8837563 [TBL] [Abstract][Full Text] [Related]
10. Thrombolysis: evidence for infarct size reduction. Martin GV; Ritchie JL J Am Coll Cardiol; 1991 Jun; 17(7):1458-60. PubMed ID: 1903405 [No Abstract] [Full Text] [Related]
11. [Status of the coronary arteries after thrombolytic therapy of myocardial infarction]. Savchenko AP Klin Med (Mosk); 1991 Jan; 69(1):13-6. PubMed ID: 2023387 [No Abstract] [Full Text] [Related]
12. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Simes RJ; Topol EJ; Holmes DR; White HD; Rutsch WR; Vahanian A; Simoons ML; Morris D; Betriu A; Califf RM Circulation; 1995 Apr; 91(7):1923-8. PubMed ID: 7895348 [TBL] [Abstract][Full Text] [Related]
13. Effects of late administration of tissue-type plasminogen activator on left ventricular remodeling and function after myocardial infarction. Bonaduce D; Petretta M; Villari B; Breglio R; Conforti G; Montemurro MV; Lanzillo T; Morgano G J Am Coll Cardiol; 1990 Dec; 16(7):1561-8. PubMed ID: 2123907 [TBL] [Abstract][Full Text] [Related]
14. [Thrombolytic therapy with tissue-type plasminogen activator]. Toma M; Yamaguchi T Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):797-801. PubMed ID: 12436618 [No Abstract] [Full Text] [Related]
15. GISSI-2 and the heparin controversy. White HD Lancet; 1990 Aug; 336(8710):297-8. PubMed ID: 1973983 [No Abstract] [Full Text] [Related]
16. Comparison of thrombolysis in myocardial infarction perfusion grades 2 and 3 after anterior wall infarction. Ishihara M; Sato H; Tateishi H; Kawagoe T; Muraoka Y; Yoshimura M Am J Cardiol; 1993 Feb; 71(5):428-30. PubMed ID: 8430632 [No Abstract] [Full Text] [Related]
17. Thrombolysis and coronary occlusion: effects upon the non-infarct zone. Cranswick R; Carter G; Wilkes N; Nelson G Eur Heart J; 1992 Jun; 13(6):770-5. PubMed ID: 1623865 [TBL] [Abstract][Full Text] [Related]
18. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group. Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934 [TBL] [Abstract][Full Text] [Related]
19. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study. Anderson JL; Karagounis LA; Becker LC; Sorensen SG; Menlove RL Circulation; 1993 Jun; 87(6):1829-39. PubMed ID: 8504495 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers. Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]